{"altmetric_id":2925140,"counts":{"readers":{"mendeley":18,"citeulike":0,"connotea":0},"total":{"posts_count":6},"twitter":{"unique_users_count":5,"unique_users":["InOncology","Immunol_papers","TumImmTx_papers","HPB_surgery","NatRevClinOncol"],"posts_count":6}},"selected_quotes":["Could herpes virus entry mediator be a key regulator of immune evasion in HCC represent a new therapeutic target?"],"citation":{"abstract":"Herpes virus entry mediator (HVEM), also known as tumour necrosis factor receptor (TNFR) superfamily 14, regulates a variety of physiological and pathological responses in both innate and acquired immunity. Although HVEM is also suggested to be a critical regulator in tumours, actual roles in human cancer are largely unknown. This study aimed to clarify clinical importance of HVEM in human hepatocellular carcinoma (HCC).","abstract_source":"pubmed","altmetric_jid":"4f6fa63c3cf058f610008e9a","doi":"10.1016\/j.ejca.2014.11.004","first_seen_on":"2014-11-26T02:37:04+00:00","issns":["0959-8049","1879-0852"],"journal":"European Journal of Cancer (1965)","last_mentioned_on":1430314751,"links":["https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=8&redirect=http%3A%2F%2Fwww.ejcancer.com%2Farticle%2FS0959-8049%252814%252901093-4%2Fabstract%3Frss%3Dyes&code=ejc-site","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?rc=9&redirect=http%3A%2F%2Fwww.ejcancer.com%2Farticle%2FS0959-8049%252814%252901093-4%2Fabstract%3Frss%3Dyes&code=ejc-site","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25468715?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pdf_url":"http:\/\/www.ejcancer.com\/article\/S0959804914010934\/pdf","pmid":"25468715","publisher":"Elsevier","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/clinical-impact-herpesvirus-entry-mediator-expression-human-hepatocellular-carcinoma"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":5038209,"mean":5.9746183047646,"rank":1241214,"this_scored_higher_than_pct":63,"this_scored_higher_than":3203802,"rank_type":"exact","sample_size":5038209,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":174153,"mean":7.954668599844,"rank":48140,"this_scored_higher_than_pct":71,"this_scored_higher_than":123677,"rank_type":"exact","sample_size":174153,"percentile":71},"this_journal":{"total_number_of_other_articles":1378,"mean":3.1618750907771,"rank":246,"this_scored_higher_than_pct":69,"this_scored_higher_than":964,"rank_type":"exact","sample_size":1378,"percentile":69},"similar_age_this_journal_3m":{"total_number_of_other_articles":39,"mean":11.865789473684,"rank":16,"this_scored_higher_than_pct":58,"this_scored_higher_than":23,"rank_type":"exact","sample_size":39,"percentile":58}}},"demographics":{"poster_types":{"member_of_the_public":4,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":4,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Unspecified":3,"Professor > Associate Professor":2,"Librarian":1,"Researcher":3,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":6,"Other":2},"by_discipline":{"Medicine and Dentistry":10,"Immunology and Microbiology":2,"Biochemistry, Genetics and Molecular Biology":3,"Unspecified":3}}},"geo":{"twitter":{"IN":1,"GB":1},"mendeley":{"US":1,"DE":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/InOncology\/status\/537434600369561601","license":"datasift","citation_ids":[2925140],"posted_on":"2014-11-26T02:36:08+00:00","author":{"name":"India Oncology 2.0","url":"https:\/\/www.facebook.com\/pages\/InOncology\/149384831739338","image":"https:\/\/pbs.twimg.com\/profile_images\/1075687841\/12_normal.png","description":"The Latest in Oncology","id_on_source":"InOncology","tweeter_id":"166079744","geo":{"lt":20,"ln":77,"country":"IN"},"followers":134},"tweet_id":"537434600369561601"},{"url":"https:\/\/twitter.com\/Immunol_papers\/status\/540518397973254144","license":"datasift","citation_ids":[2925140],"posted_on":"2014-12-04T14:50:03+00:00","author":{"name":"ImmunologyPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/507527250015576065\/AHPc4B-C_normal.png","description":"A TwitterBot for #Immunology papers on #PubMed searching for adaptive, innate and cyto\/chemokine. Curated by @ulrikstervbo. For setup see http:\/\/bit.ly\/1rwtvYu","id_on_source":"Immunol_papers","tweeter_id":"2789766403","geo":{"lt":null,"ln":null},"followers":676},"tweet_id":"540518397973254144"},{"url":"https:\/\/twitter.com\/TumImmTx_papers\/status\/540462048430141440","license":"datasift","citation_ids":[2925140],"posted_on":"2014-12-04T11:06:08+00:00","author":{"name":"TumImmTxpapers","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_normal.png","id_on_source":"TumImmTx_papers","tweeter_id":"2881001471","geo":{"lt":null,"ln":null},"followers":15},"tweet_id":"540462048430141440"},{"url":"https:\/\/twitter.com\/HPB_surgery\/status\/593357599329755136","license":"datasift","citation_ids":[2925140],"posted_on":"2015-04-29T10:14:10+00:00","author":{"name":"HPB_surgery","image":"https:\/\/pbs.twimg.com\/profile_images\/643215676610490368\/deZWut4o_normal.png","description":"HPB focused literature - as its published","id_on_source":"HPB_surgery","tweeter_id":"2581464331","geo":{"lt":null,"ln":null},"followers":371},"tweet_id":"593357599329755136"},{"url":"https:\/\/twitter.com\/Immunol_papers\/status\/593409193572339712","license":"datasift","citation_ids":[2925140],"posted_on":"2015-04-29T13:39:11+00:00","author":{"name":"ImmunologyPapers","image":"https:\/\/pbs.twimg.com\/profile_images\/507527250015576065\/AHPc4B-C_normal.png","description":"A TwitterBot for #Immunology papers on #PubMed searching for adaptive, innate and cyto\/chemokine. Curated by @ulrikstervbo. For setup see http:\/\/bit.ly\/1rwtvYu","id_on_source":"Immunol_papers","tweeter_id":"2789766403","geo":{"lt":null,"ln":null},"followers":676},"tweet_id":"593409193572339712"},{"url":"https:\/\/twitter.com\/NatRevClinOncol\/status\/540117759862906881","license":"datasift","citation_ids":[2925140],"posted_on":"2014-12-03T12:18:03+00:00","author":{"name":"NatureRevClinOncol","url":"http:\/\/www.nature.com\/nrclinonc\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1587954262\/nrclinonc_Twitter_logo_normal.jpg","description":"The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.","id_on_source":"NatRevClinOncol","tweeter_id":"347276297","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":10326},"tweet_id":"540117759862906881"}]}}